GSEP
TWST icon

Golden State Equity Partners’s Twist Bioscience TWST Stock Holding History

Golden State Equity Partners’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-42
Closed -$2K – 1644
2026
Q1 		$2K Buy
+42
New +$1.88K ﹤0.01% 1678

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Golden State Equity Partners's TWST Position: Q2 2026 in Review

Golden State Equity Partners sold out of Twist Bioscience (TWST) in Q2 2026, closing a stake of 42 shares — an estimated $2K sold.

Golden State Equity Partners first reported a position in TWST in Q1 2026 and held it in 1 quarter. The position peaked at $2K in Q1 2026. 338 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Golden State Equity Partners reported no remaining Twist Bioscience position as of Q2 2026 after selling out during the quarter.
  • Golden State Equity Partners sold 42 Twist Bioscience shares in Q2 2026, an estimated $2K.
  • Golden State Equity Partners first reported a position in Twist Bioscience in Q1 2026 and held it in 1 quarter.
  • Golden State Equity Partners's Twist Bioscience position peaked at $2K in Q1 2026.
  • 338 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Golden State Equity Partners's 13F filing for Q2 2026, filed 30 Jul 2026.